Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients

<p>Abstract</p> <p>Background</p> <p>It is known that alpha-defensin expression is enhanced in colon cancer. However, the expression of human alpha defensin 6 (DEFA 6) in earlier stages, such as adenoma, has so far not yet been studied in a patient resolved manner.</...

Full description

Bibliographic Details
Main Authors: Greulich Karl, Settmacher Utz, Glei Michael, Wilhelm Anne, Jahns Franziska, Radeva Mariya Y, Mothes Henning
Format: Article
Language:English
Published: BMC 2010-10-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/588
_version_ 1818150141762207744
author Greulich Karl
Settmacher Utz
Glei Michael
Wilhelm Anne
Jahns Franziska
Radeva Mariya Y
Mothes Henning
author_facet Greulich Karl
Settmacher Utz
Glei Michael
Wilhelm Anne
Jahns Franziska
Radeva Mariya Y
Mothes Henning
author_sort Greulich Karl
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>It is known that alpha-defensin expression is enhanced in colon cancer. However, the expression of human alpha defensin 6 (DEFA 6) in earlier stages, such as adenoma, has so far not yet been studied in a patient resolved manner.</p> <p>Methods</p> <p>By using quantitative Real Time-PCR, the gene expression pattern of <it>DEFA 1-3 </it>and <it>DEFA 6 </it>was analyzed in tissue of different stages of carcinogenesis, derived from colorectal cancer patients. In addition to paired normal and tumor tissue, matched normal near tumor and adenoma tissue samples were examined.</p> <p>Results</p> <p>The median gene expression of human defensin alpha 6 (<it>DEFA 6</it>) has been found to be moderately increased (~ 5 fold) in tumor samples derived from individuals with colorectal cancer (CRC) when compared to their normal counterparts. However, when the data were analyzed in a patient-wise manner, a large expression variation among individual patients is found, making the use of <it>DEFA 6 </it>for individual diagnosis of fully blown colon carcinoma difficult. Surprisingly, in adenoma the gene expression analysis revealed a 100 fold increased median expression of <it>DEFA 6 </it>relative to normal colon tissue. 13/18 samples had an individual overexpression of more than 60 fold in adenoma but only 3/17 in carcinoma. In each of the individual patients, at least either the adenoma or the carcinoma showed strong <it>DEFA 6 </it>overexpression.</p> <p>Conclusions</p> <p>We suggest that the expression of <it>DEFA 6 </it>preferably can be used as a potential diagnostic marker for adenoma and not as a marker for fully blown carcinoma. This is supported by the fact that <it>DEFA 6 </it>is a downstream target of the Wnt pathway, which is mutational active during the earliest stage of cancer development.</p>
first_indexed 2024-12-11T13:18:13Z
format Article
id doaj.art-301645d79c0148748d043514cbabb65a
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T13:18:13Z
publishDate 2010-10-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-301645d79c0148748d043514cbabb65a2022-12-22T01:05:58ZengBMCBMC Cancer1471-24072010-10-0110158810.1186/1471-2407-10-588Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patientsGreulich KarlSettmacher UtzGlei MichaelWilhelm AnneJahns FranziskaRadeva Mariya YMothes Henning<p>Abstract</p> <p>Background</p> <p>It is known that alpha-defensin expression is enhanced in colon cancer. However, the expression of human alpha defensin 6 (DEFA 6) in earlier stages, such as adenoma, has so far not yet been studied in a patient resolved manner.</p> <p>Methods</p> <p>By using quantitative Real Time-PCR, the gene expression pattern of <it>DEFA 1-3 </it>and <it>DEFA 6 </it>was analyzed in tissue of different stages of carcinogenesis, derived from colorectal cancer patients. In addition to paired normal and tumor tissue, matched normal near tumor and adenoma tissue samples were examined.</p> <p>Results</p> <p>The median gene expression of human defensin alpha 6 (<it>DEFA 6</it>) has been found to be moderately increased (~ 5 fold) in tumor samples derived from individuals with colorectal cancer (CRC) when compared to their normal counterparts. However, when the data were analyzed in a patient-wise manner, a large expression variation among individual patients is found, making the use of <it>DEFA 6 </it>for individual diagnosis of fully blown colon carcinoma difficult. Surprisingly, in adenoma the gene expression analysis revealed a 100 fold increased median expression of <it>DEFA 6 </it>relative to normal colon tissue. 13/18 samples had an individual overexpression of more than 60 fold in adenoma but only 3/17 in carcinoma. In each of the individual patients, at least either the adenoma or the carcinoma showed strong <it>DEFA 6 </it>overexpression.</p> <p>Conclusions</p> <p>We suggest that the expression of <it>DEFA 6 </it>preferably can be used as a potential diagnostic marker for adenoma and not as a marker for fully blown carcinoma. This is supported by the fact that <it>DEFA 6 </it>is a downstream target of the Wnt pathway, which is mutational active during the earliest stage of cancer development.</p>http://www.biomedcentral.com/1471-2407/10/588
spellingShingle Greulich Karl
Settmacher Utz
Glei Michael
Wilhelm Anne
Jahns Franziska
Radeva Mariya Y
Mothes Henning
Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
BMC Cancer
title Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
title_full Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
title_fullStr Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
title_full_unstemmed Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
title_short Defensin alpha 6 (<it>DEFA 6</it>) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
title_sort defensin alpha 6 it defa 6 it overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients
url http://www.biomedcentral.com/1471-2407/10/588
work_keys_str_mv AT greulichkarl defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT settmacherutz defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT gleimichael defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT wilhelmanne defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT jahnsfranziska defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT radevamariyay defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients
AT motheshenning defensinalpha6itdefa6itoverexpressionthresholdofover60foldcandistinguishbetweenadenomaandfullyblowncoloncarcinomainindividualpatients